Peptides for treating non-exudative macular degeneration and other eye conditions

A technique for macular degeneration, eye, applied in chemistry, pharmacy and medicine, life sciences

Pending Publication Date: 2022-03-11
急速制药有限责任公司
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

While these treatment modalities can slow the progression of dry AMD, they are not considered effective in actually reversing vision loss that has already occurred due to dry AMD

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Peptides for treating non-exudative macular degeneration and other eye conditions
  • Peptides for treating non-exudative macular degeneration and other eye conditions
  • Peptides for treating non-exudative macular degeneration and other eye conditions

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0079] The following detailed description and the drawings to which it refers are intended to describe some, but not necessarily all, examples or embodiments of the invention. The described embodiments are to be considered in all respects only as illustrative and not restrictive. The contents of this detailed description and drawings do not limit the scope of the invention in any way.

[0080] As used herein, the term "patient" or "subject" refers to a human or non-human animal, such as humans, primates, mammals, and vertebrates.

[0081] As used herein, the term "treat or treating" refers to preventing, eliminating, curing, arresting, reducing the severity of a condition, disease or disorder or reducing at least one symptom of a condition, disease or disorder.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Sensitivityaaaaaaaaaa
Login to view more

Abstract

Methods of using an anti-integrin peptide for a) improving optimal corrected vision in an eye of a subject suffering from non-exudative age-related macular degeneration and / or b) improving color vision in an eye of a subject suffering from color vision impairment and / or for treating other conditions.

Description

[0001] related application [0002] This patent application claims priority to U.S. Provisional Patent Application No. 62 / 879,281, entitled "Peptides for the Treatment of Dry Macular Degeneration and Other Eye Disorders," filed July 26, 2019, the entire disclosure of which expressly and into this article. technical field [0003] The present disclosure relates generally to the fields of chemistry, life sciences, pharmacy and medicine, and more particularly to pharmaceutical formulations and their use in the treatment of ocular disorders. Background technique [0004] Pursuant to 37 CFR 1.71(e), this patent document contains material that is protected by copyright, and all copyrights are reserved by the owner of this patent document. [0005] In this patent application, a range may be designated as "value 1 to value 2". Unless otherwise specified, the use of the word "to" in this context should be interpreted as including the stated upper and lower values ​​defining the ran...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/08C07K7/06A61P27/02A61P9/10
CPCA61K38/08A61P27/02A61K9/0048
Inventor H·L·卡拉戈齐安J·Y·帕克V·H·卡拉戈齐安
Owner 急速制药有限责任公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products